Insider trade

CME Group (CME)Director sold ~$40K

Charles P Carey, Director at CME Group, sold ~$40K of CME Group shares.

~$40K
Approx. value · 150 sh @ $265.36
5,250
Holds after · shares reported
Traded
Jun 10, 2025
Filed
Jun 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 10, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  2. Apr 8, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  3. Apr 24, 2025Insider · 1 personInsiders: 2 sales (~$528K)
  4. Apr 25, 2025InsiderDirector sold ~$532K of CME shares in the open market
  5. Apr 29, 2025InsiderDirector sold ~$271K of CME shares in the open market
  6. May 5, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  7. May 12, 2025CongressDisclosed sale of CME — reported range $15,001 - $50,000
  8. May 15, 2025Insider · 2 peopleInsiders: 2 sales (~$900K)
  9. May 19, 2025InsiderDirector sold ~$295K of CME shares in the open market
  10. May 20, 2025InsiderOfficer sold ~$108K of CME shares in the open market
  11. May 21, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  12. May 22, 2025InsiderDirector sold ~$141K of CME shares in the open market
  13. Jun 10, 2025 · this disclosureInsiderDirector sold ~$40K of CME shares in the open market

What came next

  1. Jun 10, 2025InsiderDirector sold ~$93K of CME shares in the open market
  2. Jul 22, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  3. Aug 11, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  4. Aug 14, 2025CongressDisclosed partial sale of CME — reported range $1,001 - $15,000
  5. Aug 26, 2025Insider · 1 personInsiders: 2 sales (~$3.2M)
  6. Sep 9, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 9, 2025, Jack Tobin, the Managing Director and Chief Accounting Officer of CME Group Inc. (the Company) notified the Company of his decision to retire from the Company.”
  7. Sep 16, 2025Insider · 2 peopleInsiders: 2 sales (~$196K)
  8. Sep 18, 2025InsiderOfficer sold ~$103K of CME shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for CME Group

For CME Group, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 60 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.

Other recent filings by Charles P Carey, Director

The full history of Charles P Carey, Director is on the profile page.

How this filing works

Other disclosures at CME Group

Everything OQRO holds on this company is on its CME page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data